BUZZ-Immunome drops on stock offering

** Shares of Immunome Inc IMNM.O down 10.2% to $8.40 post-market as biotech firm looks to raise equity

** Bothell, Washington-based oncology specialist commences $125 mln stock offering

** Co intends to use net proceeds to fund clinical and preclinical development of pipeline assets, and general purposes, per the SEC filing

** JP Morgan, TD Cowen, Leerink and Guggenheim are jt bookrunners

** With ~62.4 mln shares outstanding, IMNM has ~$583 mln market cap, per LSEG data

** Shares closed up 1.2% at $9.35 on Weds. Still, stock has lost 12% YTD and about 50% over the past 12 months